Article Excerpt: President Trump has deemed the opioid crisis a national emergency, though few steps have been taken thus far to minimize the impact of addictive substances like oxycodone, hydrocodone, fentanyl, and morphine. To begin tackling this enormous—and societally necessary—task, some pharmaceutical companies are developing potential solutions to treat or counteract opioid use disorder.
Full Article: https://tinyurl.com/y8gnzxsx
Article Source: MicroSmallCap